Data / Form D filings / Accretion Therapeutics, Inc.
Accretion Therapeutics, Inc.: Form D filing
Accretion Therapeutics, Inc., a pharmaceuticals company in Lincolnshire, IL, filed a Form D with the SEC in 2026. The latest, on February 17, 2026, reports $750,000 sold of a $1 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 416 OLD MILL CIR, Lincolnshire, IL, 60069
- Phone
- (847) 323-3236
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2026
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2109293
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | New notice | $1,000,000 | $750,000 | $250,000 | 1 | Feb 4, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David Holecek | Executive Officer, Director |
Every Form D from the week of Feb 16, 2026 · All recent filings in Illinois · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Accretion Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.